Clinical Trial Update: Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the combination of everolimus with letrozole or hormonal therapy for advanced, persistent, or recurrent endometrial cancer, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Everolimus (everolimus)
• Letrozole (letrozole)

Snippet

Sponsor: GOG Foundation | Conditions: Advanced, Persistent, or Recurrent Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-05-24